Publikationen, an denen er mitarbeitet Elena Eraso Barrio (80)

2024

  1. Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model

    Microbiology spectrum, Vol. 12, Núm. 1, pp. e0208623

2023

  1. Assessing pH-dependent activities of virulence factors secreted by Candida albicans

    MicrobiologyOpen, Vol. 12, Núm. 1

  2. In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates

    Journal of Fungi, Vol. 9, Núm. 6

  3. PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 12, Núm. 6, pp. 770-782

2022

  1. In vitro and in vivo anti-Candida activity of citral in combination with fluconazole

    Journal of Oral Microbiology, Vol. 14, Núm. 1

  2. Antimicrobial Peptides with Anti-Candida Activity

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  3. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  4. Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

    Journal of Fungi, Vol. 8, Núm. 7

2021

  1. Candidiasis by candida glabrata, candida nivariensis and candida bracarensis in galleria mellonella: Virulence and therapeutic responses to echinocandins

    Journal of Fungi, Vol. 7, Núm. 12

  2. Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with anti-candida activities

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 4

  3. Erratum: Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with Anti-Candida activities (Antimicrobial Agents and Chemotherapy (2021) 65:4 (e01628-20) DOI: 10.1128/AAC.01628-20)

    Antimicrobial Agents and Chemotherapy

  4. In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms

    Biomedicine and Pharmacotherapy, Vol. 143

  5. In vitro interaction and killing-kinetics of amphotericin b combined with anidulafungin or caspofungin against candida auris

    Pharmaceutics, Vol. 13, Núm. 9

  6. In vitro pharmacokinetic/pharmacodynamic modelling and simulation of amphotericin b against candida auris

    Pharmaceutics, Vol. 13, Núm. 11

  7. In vitro synergistic interactions of isavuconazole and echinocandins against Candida auris

    Antibiotics, Vol. 10, Núm. 4

  8. Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models

    Virulence, Vol. 12, Núm. 1, pp. 1063-1075

2020

  1. Caenorhabditis elegans as a Model System to Assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 10

  2. Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 25, Núm. 1, pp. 3

  3. Candida duobushaemulonii: An old but unreported pathogen

    Journal of Fungi, Vol. 6, Núm. 4, pp. 1-11

  4. Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates

    Mycoses, Vol. 63, Núm. 5, pp. 461-470